- recruitingPHASE2
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
This study looks at a new combination treatment, Atezolizumab-Bevacizumab, for liver transplant patients in the UK with advanced liver cancer that has come back. It aims to see if this treatment is safe and effective when used with special medicines to prevent organ rejection.
France - recruitingPHASE2
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
This study looks at a medicine called cabozantinib for patients who had liver cancer, received a liver transplant, and then their cancer came back. It aims to see how well cabozantinib works to control the cancer.
Canada - authorisedPhase I and Phase II (Integrated)- Other
NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase I/II explorative, open label, controlled, randomized study
This study is looking at a new medicine to protect livers from damage during a transplant operation. It's for people receiving a liver from a donor who might have had less healthy livers. The aim is to see if this medicine helps the new liver work better.
Italy